Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672195 | SCV000797275 | likely pathogenic | Primary hyperoxaluria type 3 | 2018-01-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855575 | SCV002234268 | pathogenic | not provided | 2024-02-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu150Serfs*46) in the HOGA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HOGA1 are known to be pathogenic (PMID: 22391140, 22781098). This variant is present in population databases (rs746776892, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with HOGA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 556221). For these reasons, this variant has been classified as Pathogenic. |